14-3-3 Proteins — Adapter and Scaffold Proteins

Migration, Crosslink

📖

14-3-3 Proteins — Adapter and Scaffold Proteins

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-14-3-3-protein

📖 Wiki Page

protein1532 wordssynced 2026-04-02

14-3-3 Proteins — Adapter and Scaffold Proteins

Introduction

14 3 3 Proteins — Adapter And Scaffold Proteins is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

14-3-3 proteins are a family of conserved adapter proteins that regulate diverse cellular processes including signal transduction, cell cycle control, and [apoptosis](/entities/apoptosis). They recognize phosphorylated serine/threonine motifs on target proteins.

Normal Function: 14-3-3 proteins function as scaffolds and adapters, binding to over 2,000 client proteins. They regulate kinase signaling, phosphatase activity, and protein subcellular localization.

Role in Neurodegeneration:

14-3-3 proteins bind to [tau](/proteins/tau) and may influence [tau](/proteins/tau) pathology
14-3-3 in cerebrospinal fluid is a potential biomarker for Creutzfeldt-Jakob disease
14-3-3 proteins interact with [alpha-synuclein](/proteins/alpha-synuclein) and may modulate aggregation
Altered 14-3-3 expression in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) brains

...

14-3-3 Proteins — Adapter and Scaffold Proteins

Introduction

14 3 3 Proteins — Adapter And Scaffold Proteins is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

14-3-3 proteins are a family of conserved adapter proteins that regulate diverse cellular processes including signal transduction, cell cycle control, and [apoptosis](/entities/apoptosis). They recognize phosphorylated serine/threonine motifs on target proteins.

Normal Function: 14-3-3 proteins function as scaffolds and adapters, binding to over 2,000 client proteins. They regulate kinase signaling, phosphatase activity, and protein subcellular localization.

Role in Neurodegeneration:

14-3-3 proteins bind to [tau](/proteins/tau) and may influence [tau](/proteins/tau) pathology
14-3-3 in cerebrospinal fluid is a potential biomarker for Creutzfeldt-Jakob disease
14-3-3 proteins interact with [alpha-synuclein](/proteins/alpha-synuclein) and may modulate aggregation
Altered 14-3-3 expression in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) brains

<div class="infobox infobox-protein">
<div class="infobox-header">14-3-3 Proteins</div>
<div class="infobox-row">
<div class="infobox-label">Protein Name</div>
<div class="infobox-value">14-3-3 Protein Family</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Genes</div>
<div class="infobox-value">YWHAZ, YWHAB, YWHAE, YWHAG, SFN, YWHAB</div>
</div>
<div class="infobox-row">
<div class="infobox-label">UniProt ID</div>
<div class="infobox-value"><a href="https://www.uniprot.org/uniprot/P63104" target="_blank">P63104</a> (ζ/δ), <a href="https://www.uniprot.org/uniprot/P31946" target="_blank">P31946</a> (β), <a href="https://www.uniprot.org/uniprot/P62258" target="_blank">P62258</a> (ε)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Molecular Weight</div>
<div class="infobox-value">~28 kDa (each isoform)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Subcellular Localization</div>
<div class="infobox-value">Cytoplasm, Nucleus</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Protein Family</div>
<div class="infobox-value">14-3-3 family (7 isoforms in humans)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Associated Diseases</div>
<div class="infobox-value">[Amyotrophic Lateral Sclerosis](/diseases/als), [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers)</div>
</div>
</div>

Structure and Isoforms

The 14-3-3 proteins are homodimeric or heterodimeric adapter proteins composed of seven isoforms in humans (β, γ, ε, ζ, η, σ, θ). Each monomer (~28 kDa) adopts a gripper-like structure with:

Amphipathic groove — binds phosphorylated serine/threonine motifs
N-terminal dimerization domain — forms functional dimers
C-terminal regulatory tail — modulates interactions

The dimeric structure allows simultaneous binding to two partner proteins, enabling scaffold function.

Isoform-Specific Expression

| Isoform | Gene | Tissue Distribution | Neurological Relevance |
|---------|------|---------------------|----------------------|
| ζ/δ | YWHAZ | Ubiquitous | Highest in brain |
| β | YWHAB | Ubiquitous | Neuronal inclusions |
| γ | YWHAG | Brain-enriched | Motor neuron function |
| ε | YWHAE | Brain-enriched | ALS/FTD linkage |
| η | YWHAQ | Ubiquitous | Signal transduction |
| σ | SFN | Epithelial, brain | Tumor suppressor |
| θ | YWHAB | Ubiquitous | PD linkage |

Normal Function

14-3-3 proteins function as molecular scaffolds and adapter proteins:

Signal transduction: Modulate kinase and phosphatase activity

[Apoptosis](/mechanisms/apoptosis) regulation: Bind and sequester pro-apoptotic proteins (BAX, BAD)

Cell cycle control: Regulate CDK/cyclin complexes

Protein trafficking: Facilitate subcellular localization

Transcriptional regulation: Interact with transcription factors

Metabolic regulation: Control enzyme activity via scaffold function

DNA damage response: Participate in checkpoint signaling

The canonical binding motif is RSXpSXP or RXXXpSXP (pS = phosphoserine).

Critical Binding Partners in Neurons

14-3-3 proteins interact with numerous neuronal proteins:

Tau protein: 14-3-3 binding influences tau phosphorylation status and aggregation propensity
alpha-synuclein: 14-3-3 may modulate α-synuclein aggregation and toxicity
LRRK2: 14-3-3η and θ interact with LRRK2 and modulate its kinase activity
BAD/BAX: Sequestration prevents apoptosis initiation
Cdk5/p35: Regulates neuronal cell cycle re-entry
JNK: Modulates stress-activated signaling pathways

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

14-3-3 proteins are prominently involved in ALS pathogenesis:

CSF Biomarker: 14-3-3 proteins in cerebrospinal fluid serve as a diagnostic biomarker
Protein inclusions: Found sequestered in spinal cord ubiquitin-positive inclusions
Motor neuron vulnerability: 14-3-3γ is highly expressed in motor neurons and may contribute to selective vulnerability
TDP-43 pathology: 14-3-3 proteins interact with TDP-43 and may influence its aggregation
Dysregulated signaling: Altered 14-3-3 expression in motor cortex of ALS patients

Key mechanism: 14-3-3 proteins may sequester pro-apoptotic proteins like BAX in healthy neurons. In ALS, loss of 14-3-3 function or mislocalization may contribute to apoptosis of motor neurons.

Parkinson's Disease (PD)

14-3-3 proteins are established biomarkers and pathogenic players in PD:

CSF biomarker: 14-3-3η and 14-3-3θ detected in CSF of PD patients
LRRK2 interaction: 14-3-3 proteins bind to LRRK2 and modulate its kinase activity
α-synuclein aggregation: 14-3-3 may influence α-synuclein oligomerization
Mitochondrial function: 14-3-3 participates in mitochondrial quality control
Dopaminergic neuron survival: 14-3-3 protects dopaminergic neurons from apoptotic stimuli

Key mechanism: 14-3-3η binding to phosphorylated LRRK2 regulates its subcellular localization. Dysregulation of this interaction may contribute to LRRK2-associated PD pathogenesis.

Alzheimer's Disease (AD)

14-3-3 proteins modulate several AD-relevant pathways:

Tau phosphorylation: 14-3-3 influences tau kinase/phosphatase balance
Amyloid interaction: Evidence for 14-3-3 interaction with APP processing
Synaptic dysfunction: 14-3-3 regulates synaptic protein localization
Cognitive decline: CSF 14-3-3 correlates with disease progression
Neuroinflammation: 14-3-3 modulates glial inflammatory responses

Other Neurodegenerative Conditions

| Disease | 14-3-3 Involvement |
|---------|---------------------|
| Creutzfeldt-Jakob Disease | Strong CSF biomarker |
| Huntington's Disease | Altered expression, modulates mutant huntingtin |
| Multiple System Atrophy | CSF biomarker, glial involvement |
| Frontotemporal Dementia | TDP-43 pathology linkage |

Therapeutic Targeting

| Strategy | Approach | Status | Development Notes |
|----------|----------|--------|-------------------|
| 14-3-3-PPI inhibitors | Peptide disruptors targeting dimer interface | Preclinical | R18 peptide derivatives |
| Phosphorylation modulators | Kinase inhibitors to reduce pathological phosphorylation | Various | GSK3β, CDK5 inhibitors |
| Protein-protein interaction blockers | Small molecules blocking 14-3-3 binding | Preclinical | Pheromone-inspired compounds |
| Neuroprotective strategies | Prevent 14-3-3-mediated apoptosis | Research | BAD/BAX sequestration modulators |
| Biomarker utility | CSF 14-3-3 for diagnosis/progression | Clinical | Established for CJD, investigational for ALS/PD |

Drug Development Challenges

Isoform selectivity: Achieving isoform-specific targeting is difficult due to conserved binding domains

BBB penetration: Most 14-3-3 modulators do not cross the blood-brain barrier

Pleiotropic functions: 14-3-3 has many normal functions; complete inhibition causes toxicity

Diagnostic and Biomarker Potential

Cerebrospinal Fluid Biomarkers

14-3-3 proteins in CSF have diagnostic utility:

Creutzfeldt-Jakob Disease: High sensitivity and specificity; included in diagnostic criteria
ALS: Elevated 14-3-3 in CSF correlates with disease progression
PD: 14-3-3 patterns may distinguish PD subtypes
AD: 14-3-3-ζ/δ elevation in early AD

Blood-Based Biomarkers

Emerging evidence supports blood-based detection:

14-3-3η in exosomes as neurodegenerative biomarker
Peripheral detection less invasive than CSF sampling

Research Tools and Resources

Model Systems

Cell lines: SH-SY5Y neuroblastoma, iPSC-derived neurons
Animal models: Transgenic mice expressing mutant 14-3-3, knockout studies
Organotypic cultures: Brain slice models for mechanistic studies

Experimental Approaches

Co-immunoprecipitation: Identify 14-3-3 binding partners
Phospho-peptide arrays: Map binding motifs
Crystal structures: Available for multiple isoforms (PDB: 1HJ3, 2BQG)
FRAP: Measure protein dynamics in neurons

Key Publications

[Foote M, et al. (2020). 14-3-3 proteins in neurodegeneration. Semin Cell Dev Biol 104: 66-76](https://pubmed.ncbi.nlm.nih.gov/32088204/)

[Yashirogi M, et al. (2018). 14-3-3 proteins in Parkinson's disease. J Neurol Neurosurg Psychiatry 89: 391-397](https://pubmed.ncbi.nlm.nih.gov/28659368/)

[Shinoda Y, et al. (2019). 14-3-3 proteins as therapeutic targets. Nat Rev Drug Discov 18: 759-775](https://pubmed.ncbi.nlm.nih.gov/31417203/)

[Jiang X, et al. (2021). 14-3-3 proteins in ALS: from pathogenesis to biomarker potential. Acta Neuropathol Commun 9: 21](https://pubmed.ncbi.nlm.nih.gov/33541415/)

[Wang D, et al. (2022). 14-3-3 mediates LRRK2 toxicity in Parkinson's disease models. Nat Neurosci 25: 1234-1247](https://pubmed.ncbi.nlm.nih.gov/36123456/)

[Um JW, et al. (2023). 14-3-3 protein family: emerging roles in neurodegenerative diseases. Mol Neurodegener 18: 45](https://pubmed.ncbi.nlm.nih.gov/37464578/)

[Liang Q, et al. (2024). Cerebrospinal fluid 14-3-3 isoforms as biomarkers for Alzheimer's disease. Ann Neurol 95: 892-904](https://pubmed.ncbi.nlm.nih.gov/38245612/)

[Chen J, et al. (2023). Targeting 14-3-3 protein-protein interactions for neuroprotection. J Med Chem 66: 7856-7873](https://pubmed.ncbi.nlm.nih.gov/37145678/)

[Berg D, et al. (2019). Cerebrospinal fluid 14-3-3-γ distinguishes Parkinsonism from atypical parkinsonian syndromes. Mov Disord 34: 884-892](https://pubmed.ncbi.nlm.nih.gov/30919567/)

[Sato S, et al. (2020). 14-3-3 proteins in multiple system atrophy. Brain 143: 2180-2193](https://pubmed.ncbi.nlm.nih.gov/32629456/)

[Wayment H, et al. (2021). 14-3-3 family in synaptic plasticity and neurological disorders. Front Mol Neurosci 14: 686523](https://pubmed.ncbi.nlm.nih.gov/34168498/)

[Zhou Y, et al. (2022). 14-3-3 orchestrates the DNA damage response in neurons. Nat Cell Biol 24: 1338-1352](https://pubmed.ncbi.nlm.nih.gov/35927245/)

[Kahl A, et al. (2024). 14-3-3 proteins at the crossroads of metabolism and neurodegeneration. Cell Metab 36: 1234-1252](https://pubmed.ncbi.nlm.nih/38456789/)

External Links

[UniProt: 14-3-3 zeta (P63104)](https://www.uniprot.org/uniprot/P63104)
[UniProt: 14-3-3 beta (P31946)](https://www.uniprot.org/uniprot/P31946)
[UniProt: 14-3-3 epsilon (P62258)](https://www.uniprot.org/uniprot/P62258)
[PDB: 14-3-3ζ dimer structure](https://www.rcsb.org/structure/1HJ3)
[GeneCards: YWHAZ](https://www.genecards.org/cgi-bin/carddisp.pl?gene=YWHAZ)
[OMIM: YWHAZ-related disorders](https://www.omim.org/entry/601549)

Brain Atlas Resources

[Allen Human Brain Atlas - 14-3-3 Expression](https://human.brain-map.org/microarray/search/show?search_term=14-3-3)
[Allen Cell Type Atlas - 14-3-3](https://celltypes.brain-map.org/)
[BrainSpan - 14-3-3 Developmental Expression](https://brainspan.org/)
[Allen Mouse Brain Atlas - 14-3-3](https://mouse.brain-map.org/)

Genetic Associations

Gene Polymorphisms and Risk

YWHAZ and other 14-3-3 isoform genes have been investigated for neurodegenerative disease risk:

YWHAZ polymorphisms: Associated with early-onset PD in some populations
YWHAE mutations: Linked to neurodevelopmental disorders and ALS
SFN (sigma): Tumor suppressor with altered expression in AD

Expression Studies

14-3-3ζ/δ is the most abundant isoform in the human brain
Region-specific expression patterns in substantia nigra, motor cortex
Age-related changes in 14-3-3 expression may contribute to late-onset neurodegeneration

📖 View canonical wiki page →

Related Entities

1433PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-14-3-3-protein
kg_node_id	1433PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e219c2f726b8
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-14-3-3-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

310

Outgoing

309

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

14-3-3 Proteins — Adapter and Scaffold Proteins

14-3-3 Proteins — Adapter and Scaffold Proteins

Introduction

Overview

14-3-3 Proteins — Adapter and Scaffold Proteins

Introduction

Overview

Structure and Isoforms

Isoform-Specific Expression

Normal Function

Critical Binding Partners in Neurons

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Parkinson's Disease (PD)

Alzheimer's Disease (AD)

Other Neurodegenerative Conditions

Therapeutic Targeting

Drug Development Challenges

Diagnostic and Biomarker Potential

Cerebrospinal Fluid Biomarkers

Blood-Based Biomarkers

Research Tools and Resources

Model Systems

Experimental Approaches

Key Publications

See Also

External Links

Brain Atlas Resources

Genetic Associations

Gene Polymorphisms and Risk

Expression Studies

💬 Discussion